Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
2025
Safety Committee Backs PH-762 Dose-Escalation in Skin Cancer Trial
A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma.
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Melanoma: Age-Related Biological Changes Cause Tumors to Spread
In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor make melanoma, a deadly skin cancer, more likely to spread in patients age 70 and older. Their research, published in the peer-reviewed journal Cancer Research, could lead to new therapies to help prevent melanoma metastasis.